Multiple sclerosis: novel perspectives on newly forming lesions

Carlos Matute1, Fernando Pérez-Cerdá

  • 1Departamento de Neurociencias, Universidad del País Vasco, E-48940 Leioa, Vizcaya, Spain. onpmaalc@lg.ehu.es

Insights

Mechanisms of multiple sclerosis lesion formation are unclear. While macrophages were thought to mediate myelin destruction, new findings show oligodendrocyte apoptosis without significant immune cell involvement, suggesting a new disease pathway.

Area of Science:

  • Neuroimmunology
  • Pathogenesis of Demyelinating Diseases

Background:

  • Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system.
  • The precise mechanisms driving lesion formation in MS remain incompletely understood.
  • Macrophages are traditionally considered key effectors of myelin damage in relapsing-remitting MS.

Purpose of the Study:

  • To investigate the cellular mechanisms involved in the early stages of multiple sclerosis lesion development.
  • To re-evaluate the role of immune cells versus intrinsic oligodendrocyte pathology in demyelination.

Main Methods:

  • Histopathological analysis of central nervous system tissue from MS patients.
  • Immunohistochemistry to identify cell types and markers of apoptosis.
  • Correlation of cellular findings with disease activity and clinical presentation.

Main Results:

  • Widespread apoptosis of oligodendrocytes was observed in MS lesions.
  • Evidence of significant immune cell infiltration, particularly macrophages, was often lacking.
  • Oligodendrocyte death occurred independently of a robust cellular immune response.

Conclusions:

  • The findings challenge the prevailing view of macrophage-mediated myelin destruction as the sole driver of MS lesions.
  • Oligodendrocyte apoptosis represents a significant, potentially primary, mechanism in MS pathogenesis.
  • Further research into non-immune-mediated pathways of demyelination is warranted for understanding MS.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...